Viewing StudyNCT00761384



Ignite Creation Date: 2024-05-05 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 9:55 AM
Study NCT ID: NCT00761384
Status: COMPLETED
Last Update Posted: 2016-02-19
First Post: 2008-09-26

Brief Title: High Dose Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells PBSC Support in B-cell Lymphoma
Sponsor:
Organization: Lund University Hospital

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 7
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: